WTAP-mediated m6A modification of lncRNA DIAPH1-AS1 enhances its stability to facilitate nasopharyngeal carcinoma growth and metastasis

被引:0
|
作者
Zhi-Xuan Li
Zi-Qi Zheng
Pan-Yang Yang
Li Lin
Guan-Qun Zhou
Jia-Wei Lv
Lu-Lu Zhang
FoPing Chen
Ying-Qin Li
Chen-Fei Wu
Feng Li
Jun Ma
Na Liu
Ying Sun
机构
[1] Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy
[2] Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Department of Molecular Diagnostics
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
As the most predominant RNA epigenetic regulation in eukaryotic cells, N6-methyladenosine (m6A) plays a critical role in human tumorigenesis and cancer progression. However, the biological function and molecular mechanism of m6A regulation in naso-pharyngeal carcinoma (NPC) remain elusive. Here, we showed that Wilms’ tumor 1-associating protein (WTAP) expression was apparently upregulated in NPC, and increased WTAP was associated with poor prognosis. WTAP upregulated in NPC was fine-tuned by KAT3A-mediated H3K27 acetylation. Functionally, WTAP was required for the growth and metastasis of NPC. Mechanistically, lncRNA DIAPH1-AS1 was identified as a bona fide m6A target of WTAP. WTAP-mediated m6A modification of DIAPH1-AS1 enhanced its stability relying on the m6A reader IGF2BP2-dependent pathway. Furthermore, DIAPH1-AS1 acted as a molecular adaptor that promoted MTDH-LASP1 complex formation and upregulated LASP1 expression, ultimately facilitating NPC growth and metastasis. Thus, WTAP-mediated DIAPH1-AS1 m6A methylation is required for NPC tumorigenesis and metastasis.
引用
收藏
页码:1137 / 1151
页数:14
相关论文
共 50 条
  • [1] WTAP-mediated m6A modification of lncRNA DIAPH1-AS1 enhances its stability to facilitate nasopharyngeal carcinoma growth and metastasis
    Li, Zhi-Xuan
    Zheng, Zi-Qi
    Yang, Pan-Yang
    Lin, Li
    Zhou, Guan-Qun
    Lv, Jia-Wei
    Zhang, Lu-Lu
    Chen, FoPing
    Li, Ying-Qin
    Wu, Chen-Fei
    Li, Feng
    Ma, Jun
    Liu, Na
    Sun, Ying
    CELL DEATH AND DIFFERENTIATION, 2022, 29 (06): : 1137 - 1151
  • [2] WTAP-mediated m6A modification on BASP1 mRNA contributes to ferroptosis in AAA
    Tian, Zexiang
    Li, Wei
    Wang, Jian
    Li, Shuzhen
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2025,
  • [3] Author Correction: WTAP-mediated m6A modification of lncRNA NORAD promotes intervertebral disc degeneration
    Gaocai Li
    Liang Ma
    Shujie He
    Rongjin Luo
    Bingjin Wang
    Weifeng Zhang
    Yu Song
    Zhiwei Liao
    Wencan Ke
    Qian Xiang
    Xiaobo Feng
    Xinghuo Wu
    Yukun Zhang
    Kun Wang
    Cao Yang
    Nature Communications, 13
  • [4] WTAP-mediated m6A modification of lncRNA NORAD promotes intervertebral disc degeneration (vol 13, 1469, 2022)
    Li, Gaocai
    Ma, Liang
    He, Shujie
    Luo, Rongjin
    Wang, Bingjin
    Zhang, Weifeng
    Song, Yu
    Liao, Zhiwei
    Ke, Wencan
    Xiang, Qian
    Feng, Xiaobo
    Wu, Xinghuo
    Zhang, Yukun
    Wang, Kun
    Yang, Cao
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [5] WTAP-mediated m6A modification on circCMTM3 inhibits hepatocellular carcinoma ferroptosis by recruiting IGF2BP1 to increase PARK7 stability
    Chen, Shuwei
    Xia, Hongxiang
    Sheng, Langqing
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (07) : 967 - 981
  • [6] WTAP-mediated m6A modification regulates NLRP3/Caspase-1/GSDMD to inhibit pyroptosis and exacerbate colorectal cancer
    Mo, Anwei
    Wang, Huaiwen
    BIOMARKERS IN MEDICINE, 2024,
  • [7] HBXIP induces PARP1 via WTAP-mediated m6A modification and CEBPA-activated transcription in cisplatin resistance to hepatoma
    Fu, Xue-li
    Guo, Shi-man
    Ma, Jia-qi
    Ma, Fang-yuan
    Wang, Xue
    Tang, Yan-xin
    Li, Ye
    Zhang, Wei-ying
    Ye, Li-hong
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (11) : 2405 - 2419
  • [8] WTAP-mediated m6A modification of TRIM22 promotes diabetic nephropathy by inducing mitochondrial dysfunction via ubiquitination of OPA1
    Zhang, Zeng
    Zhou, Fengzhu
    Lu, Min
    Zhang, Duanchun
    Zhang, Xinyi
    Xu, Siyu
    He, Yanming
    REDOX REPORT, 2024, 29 (01)
  • [9] WTAP-mediated m6A modification of lncRNA Snhg1 improves myocardial ischemia-reperfusion injury via miR-361-5p/OPA1-dependent mitochondrial fusion
    Liu, Linlin
    Wu, Jiahong
    Lu, Cheng
    Ma, Yan
    Wang, Jiayi
    Xu, Jie
    Yang, Xiaoli
    Zhang, Xuan
    Wang, Hua
    Xu, Jieyu
    Zhang, Jiehan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [10] m6A modification of lncRNA PHKA1-AS1 enhances Actinin Alpha 4 stability and promotes non-small cell lung cancer metastasis
    Guo, Qiao-Ru
    Zhang, Guo-Bin
    Zhou, Wen-Min
    Lu, Yu
    Chen, Xin-Zhu
    Deng, Zhuo-Fen
    Li, Jin-Shuo
    Bi, Hong
    Wu, Ming-Sheng
    Xie, Ming-Ran
    Yan, Yan-Yan
    Zhang, Jian-Ye
    MEDCOMM, 2024, 5 (06):